Caseware UK (AP4) 2023.0.135 2023.0.135 2024-03-312024-03-312023-04-01falseNo description of principal activity22truetrueThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.false OC398935 2023-04-01 2024-03-31 OC398935 2022-04-01 2023-03-31 OC398935 2024-03-31 OC398935 2023-03-31 OC398935 c:MotorVehicles 2023-04-01 2024-03-31 OC398935 c:MotorVehicles 2024-03-31 OC398935 c:MotorVehicles 2023-03-31 OC398935 c:MotorVehicles c:OwnedOrFreeholdAssets 2023-04-01 2024-03-31 OC398935 c:FurnitureFittings 2023-04-01 2024-03-31 OC398935 c:FurnitureFittings 2024-03-31 OC398935 c:FurnitureFittings 2023-03-31 OC398935 c:FurnitureFittings c:OwnedOrFreeholdAssets 2023-04-01 2024-03-31 OC398935 c:OwnedOrFreeholdAssets 2023-04-01 2024-03-31 OC398935 c:CurrentFinancialInstruments 2024-03-31 OC398935 c:CurrentFinancialInstruments 2023-03-31 OC398935 c:CurrentFinancialInstruments c:WithinOneYear 2024-03-31 OC398935 c:CurrentFinancialInstruments c:WithinOneYear 2023-03-31 OC398935 c:Non-currentFinancialInstruments c:AfterOneYear 2024-03-31 OC398935 c:Non-currentFinancialInstruments c:AfterOneYear 2023-03-31 OC398935 d:FRS102 2023-04-01 2024-03-31 OC398935 d:AuditExempt-NoAccountantsReport 2023-04-01 2024-03-31 OC398935 d:FullAccounts 2023-04-01 2024-03-31 OC398935 d:LimitedLiabilityPartnershipLLP 2023-04-01 2024-03-31 OC398935 c:HirePurchaseContracts c:WithinOneYear 2024-03-31 OC398935 c:HirePurchaseContracts c:WithinOneYear 2023-03-31 OC398935 c:HirePurchaseContracts c:BetweenOneFiveYears 2024-03-31 OC398935 c:HirePurchaseContracts c:BetweenOneFiveYears 2023-03-31 OC398935 d:PartnerLLP1 2023-04-01 2024-03-31 OC398935 c:FurtherSpecificReserve3ComponentTotalEquity 2024-03-31 OC398935 c:FurtherSpecificReserve3ComponentTotalEquity 2023-03-31 OC398935 e:PoundSterling 2023-04-01 2024-03-31 iso4217:GBP xbrli:pure

Registered number: OC398935









CAPSTONE LIFE SCIENCES LLP







UNAUDITED

FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE YEAR ENDED 31 MARCH 2024

 
CAPSTONE LIFE SCIENCES LLP
REGISTERED NUMBER: OC398935

STATEMENT OF FINANCIAL POSITION
AS AT 31 MARCH 2024

2024
2023
Note
£
£

Fixed assets
  

Tangible assets
 4 
62,247
64,865

  
62,247
64,865

Current assets
  

Debtors: amounts falling due within one year
 5 
-
3,631

Cash at bank and in hand
 6 
15,085
8,718

  
15,085
12,349

Creditors: Amounts Falling Due Within One Year
 7 
(15,428)
(7,840)

Net current (liabilities)/assets
  
 
 
(343)
 
 
4,509

Total assets less current liabilities
  
61,904
69,374

Creditors: amounts falling due after more than one year
  
(42,386)
(58,859)

  
19,518
10,515

  

Net assets
  
19,518
10,515


Represented by:
  

Loans and other debts due to members within one year
  

Other amounts
 9 
19,518
10,515

  
19,518
10,515

  

  
19,518
10,515


Total members' interests
  

Loans and other debts due to members
 9 
19,518
10,515

  
19,518
10,515


Page 1

 
CAPSTONE LIFE SCIENCES LLP
REGISTERED NUMBER: OC398935
    
STATEMENT OF FINANCIAL POSITION (CONTINUED)
AS AT 31 MARCH 2024

The financial statements have been prepared in accordance with the provisions applicable to entities subject to the small LLPs regime.

The entity was entitled to exemption from audit under section 477 of the Companies Act 2006, as applied by The Limited Liability Partnerships (Accounts and Audit) (Application of Companies Act 2006) Regulations 2008.

The members acknowledge their responsibilities for complying with the requirements of the Companies Act 2006, as applied by The Limited Liability Partnerships (Accounts and Audit) (Application of Companies Act 2006) Regulations 2008, with respect to accounting records and the preparation of financial statements.

The financial statements have been delivered in accordance with the provisions applicable to LLPs subject to the small LLPs regime.

The entity has opted not to file the statement of comprehensive income in accordance with the provisions applicable to entities subject to the small LLPs regime.

The financial statements were approved and authorised for issue by the members and were signed on their behalf by: 




L Cohen
Designated member

Date: 28 November 2024

The notes on pages 3 to 6 form part of these financial statements.

Capstone Life Sciences LLP has no equity and, in accordance with the provisions contained within the Statement of Recommended Practice "Accounting by Limited Liability Partnerships", has not presented a Statement of Changes in Equity.

Page 2

 
CAPSTONE LIFE SCIENCES LLP
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024

1.


General information

Capstone Life Sciences LLP is a limited liability partnership incorporated in England. Its registered office is 101,New Cavendish Steet, London, 1st Floor South, London, W1W 6XH . 

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

 
2.2

Revenue

Turnover is recognised to the extent that it is probable that the economic benefits will flow to the LLP and the turnover can be reliably measured. Turnover is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before turnover is recognised:

Rendering of services

Turnover from a contract to provide services is recognised in the period in which the services are provided in accordance with the stage of completion of the contract when all of the following conditions are satisfied:
the amount of turnover can be measured reliably;
it is probable that the LLP will receive the consideration due under the contract;
the stage of completion of the contract at the end of the reporting period can be measured reliably; and
the costs incurred and the costs to complete the contract can be measured reliably.

 
2.3

Finance costs

Finance costs are charged to profit or loss over the term of the debt using the effective interest method so that the amount charged is at a constant rate on the carrying amount. Issue costs are initially recognised as a reduction in the proceeds of the associated capital instrument.

 
2.4

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Page 3

 
CAPSTONE LIFE SCIENCES LLP
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024

2.Accounting policies (continued)


2.4
Tangible fixed assets (continued)

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, on a reducing balance basis.

Depreciation is provided on the following basis:

Motor vehicles
-
20% Reducing balance method
Fixtures and fittings
-
25% Reducing balance method

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.


3.


Employees

The average monthly number of employees, including directors, during the year was 2 (2023 - 2).


4.


Tangible fixed assets





Motor vehicles
Fixtures and fittings
Total

£
£
£



Cost or valuation


At 1 April 2023
60,590
16,559
77,149


Additions
-
3,677
3,677



At 31 March 2024

60,590
20,236
80,826



Depreciation


At 1 April 2023
4,039
8,245
12,284


Charge for the year on owned assets
3,770
2,525
6,295



At 31 March 2024

7,809
10,770
18,579



Net book value



At 31 March 2024
52,781
9,466
62,247



At 31 March 2023
56,551
8,314
64,865

Page 4

 
CAPSTONE LIFE SCIENCES LLP
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024

5.


Debtors

2024
2023
£
£


Trade debtors
-
3,631

-
3,631



6.


Cash and cash equivalents

2024
2023
£
£

Cash at bank and in hand
15,085
8,718

15,085
8,718



7.


Creditors: Amounts falling due within one year

2024
2023
£
£

Other taxation and social security
4,337
6,090

Obligations under finance lease and hire purchase contracts
8,091
-

Accruals and deferred income
3,000
1,750

15,428
7,840



8.


Hire purchase and finance leases


Minimum lease payments under hire purchase fall due as follows:

2024
2023
£
£


Within one year
8,091
10,391

Between 1-5 years
42,386
48,468

50,477
58,859

Page 5

 
CAPSTONE LIFE SCIENCES LLP
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024

9.


Loans and other debts due to members


2024
2023
£
£



Other amounts due to members
(19,518)
(10,515)

19,518
10,515

Loans and other debts due to members may be further analysed as follows:

2024
2023
£
£



Falling due within one year
(19,518)
(10,515)

19,518
10,515

Loans and other debts due to members rank equally with debts due to ordinary creditors in the event of a winding up.

 
Page 6